The alternative CD20 transcript variant is not a surrogate marker for resistance to rituximab in patients with rheumatoid arthritis: Fig. 1 Journal article
Gamonet Clémentine, Deschamps Marina, Marion Sandrine, Herbein Georges, Chiocchia Gilles, Auger Isabelle, Saas Philippe, Ferrand Christophe, Toussirot Eric
Journal title: Rheumatology, Volume(s): 54, Issue(s): 9, Page(s): 1744-1745 https://inserm.hal.science/inserm-04171983/document 10.1093/rheumatology/kev210 (2015)